Computational simulations of nanoparticle transport in a three-dimensional capillary network

Document Type : Research Paper

Authors

1 Department of Physics and Medical Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Medical Physics, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Abstract

Objective(s): Multifunctional nanomedicine is the new generation of medicine, which is remarkably promising and associated with the minimum toxicity of targeted therapy. Distribution and transport of nanoparticles (NPs) in the blood flow are essential to the evaluation of delivery efficacy.
Materials and Methods: In the present study, we initially designed a phantom based on Murray’s minimum work law using the AutoCAD software. Afterwards, the phantom was fabricated using lithography and imaged using a Siemens Magnetom 3T Prisma MRI scanner at the National Brain Mapping Laboratory, Iran. Finally, the velocity and pressure in the capillary network were simulated using the COMSOL software. Moreover, three-dimensional Navier-Stokes equations were applied to model the NP transport and dispersion in blood suspension.
Results: According to the findings, particle size, vessel geometry, and vascular flow rate affected the delivery efficacy and NP distribution. Cerebral blood flow, cerebral blood volume, mean transit time, and curves for the capillary network were obtained at different times. The simulations indicated that the velocity and pressure in the capillary network were within the ranges of 0.0001-0.0005 m/s and 5-25 mm/Hg, respectively. Higher particle concentration was also observed in the non-uniform NP distribution profile near the vessel wall.
Conclusion: We investigated the effects of the vessel size and geometry and particulate nature of blood on the delivery and distribution of NPs. For targeted drug delivery applications, a mechanistic understanding on the nanomedicine design was provided as well.

Keywords


1.Wang T, Yang S, Petrenko VA, Torchilin VP. Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein. Mol Pharm. 2010; 7(4): 1149-1158.
2.Al-Jamal WT, Kostarelos K. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Acc Chem Res. 2011;44(10):1094-1104.
3.Choudhury RP, Fuster V, Fayad ZA. Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discov 2004;3(11): 913.
4.Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2005; 16(1): 63-72.
5.Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: A novel drug− carrier system for photodynamic therapy. J Am Chem Soc. 2003;125(26): 7860-7865.
6.Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc. 2006;128(6): 2115-2120.
7.Sardar R, Shumaker-Parry JS. Asymmetrically functionalized gold nanoparticles organized in one-dimensional chains. Nanoscale Res Lett 2008; 8(2): 731-736.
8.Park JH, von Maltzahn G, Zhang L, Derfus AM, Simberg D, Harris TJ, et al. Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. small. 2009;5(6): 694-700.
9.Dai Q, Worden JG, Trullinger J, Huo Q. A “nanonecklace” synthesized from monofunctionalized gold nanoparticles. Journal of the American Chemical Society. 2005; 127(22) :8008-8009.
10.Decuzzi P, Ferrari M. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials. 2006; 27(30): 5307-5314.
11.Kety SS, Schmidt CF. The determination of cerebral blood flow in man by the use of nitrous oxide in low concentrations. Am J Physiol 1945;143(1): 53-66.
12.Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954 ;6(12): 731-744.
13.Shurche S, Alam NR. Simulation of Capillary Hemodynamics and Comparison with Experimental Results of Microphantom Perfusion Weighted Imaging. J Biomed Phys Eng 2019.
14.Mehta A, Jones BP. Neurovascular Diseases. Grainger & Allison’s Diagnostic Radiology: Neuroimaging. 2015: 68.
15.Murray CD. The physiological principle of minimum work: I. The vascular system and the cost of blood volume. Proc Natl Acad Sci U S A 1926; 12(3): 207.
16.Rossitti S, Löfgren J. Vascular dimensions of the cerebral arteries follow the principle of minimum work. Stroke. 1993; 24(3): 371-377.
17.Emerson DR, Cieślicki K, Gu X, Barber RW. Biomimetic design of microfluidic manifolds based on a generalised Murray’s law. Lab Chip. 2006; 6(3): 447-454.
18.Pawlik G, Rackl A, Bing RJ. Quantitative capillary topography and blood flow in the cerebral cortex of cats: an in vivo microscopic study. Brain Res. 1981; 208(1): 35-58.
19.Cassot F, Lauwers F, Fouard C, Prohaska S, LAUWERS‐CANCES V. A novel three‐dimensional computer‐assisted method for a quantitative study of microvascular networks of the human cerebral cortex. Microcirculation. 2006; 13(1): 1-18.
20.Vignon-Clementel IE, Figueroa CA, Jansen KE, Taylor CA. Outflow boundary conditions for three-dimensional finite element modeling of blood flow and pressure in arteries. Comput Methods Appl Mech Eng. 2006; 195(29-32): 3776-3796.
21.Arbia G, Corsini C, Moghadam ME, Marsden AL, Migliavacca F, Pennati G, et al. Numerical blood flow simulation in surgical corrections: what do we need for an accurate analysis? JAMA Surg. 2014; 186(1): 44-55.
22.Ivanov K, Kalinina M, Levkovich YI. Blood flow velocity in capillaries of brain and muscles and its physiological significance. Microvasc Res 1981; 22(2): 143-155.
23.Shore AC. Capillaroscopy and the measurement of capillary pressure. Br J Clin Pharmacol 2000; 50(6): 501-513.
24.Calamante F, Mørup M, Hansen LK. Defining a local arterial input function for perfusion MRI using independent component analysis. Magn Reson Med. 2004; 52(4): 789-797.